Literature DB >> 19914728

Mortality attributable to diabetes: estimates for the year 2010.

Gojka Roglic1, Nigel Unwin.   

Abstract

Country and global health statistics underestimate the number of excess deaths due to diabetes. The aim of the study was to provide a more accurate estimate of the number of deaths attributable to diabetes for the year 2010. A computerized disease model was used to obtain the estimates. The baseline input data included the population structure, estimates of diabetes prevalence, estimates of underlying mortality and estimates of the relative risk of death for people with diabetes compared to people without diabetes. The total number of excess deaths attributable to diabetes worldwide was estimated to be 3.96 million in the age group 20-79 years, 6.8% of global (all ages) mortality. Diabetes accounted for 6% of deaths in adults in the African Region, to 15.7% in the North American Region. Beyond 49 years of age diabetes constituted a higher proportion of deaths in females than in males in all regions, reaching over 25% in some regions and age groups. Thus, diabetes is a considerable cause of premature mortality, a situation that is likely to worsen, particularly in low and middle income countries as diabetes prevalence increases. Investments in primary and secondary prevention are urgently required to reduce this burden. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19914728     DOI: 10.1016/j.diabres.2009.10.006

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  107 in total

1.  Association study of polymorphisms in FOXO3, AKT1 and IGF-2R genes with human longevity in a Han Chinese population.

Authors:  Ning Li; Huaichao Luo; Xiaoqi Liu; Shi Ma; He Lin; Rong Chen; Fang Hao; Dingding Zhang
Journal:  Oncotarget       Date:  2016-01-05

2.  Restoration of defective L-type Ca2+ current in cardiac myocytes of type 2 diabetic db/db mice by Akt and PKC-ι.

Authors:  Zhongju Lu; Lisa M Ballou; Ya-Ping Jiang; Ira S Cohen; Richard Z Lin
Journal:  J Cardiovasc Pharmacol       Date:  2011-10       Impact factor: 3.105

3.  Racial-ethnic disparities in the association between risk factors and diabetes: The Northern Manhattan Study.

Authors:  Erin R Kulick; Yeseon P Moon; Ken Cheung; Joshua Z Willey; Ralph L Sacco; Mitchell S V Elkind
Journal:  Prev Med       Date:  2015-12-04       Impact factor: 4.018

Review 4.  Sitagliptin: a review of its use in patients with type 2 diabetes mellitus.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

5.  Global burden of disease--where does diabetes mellitus fit in?

Authors:  K George M M Alberti; Paul Zimmet
Journal:  Nat Rev Endocrinol       Date:  2013-03-12       Impact factor: 43.330

Review 6.  Minimally Disruptive Medicine for Patients with Diabetes.

Authors:  Valentina Serrano; Gabriela Spencer-Bonilla; Kasey R Boehmer; Victor M Montori
Journal:  Curr Diab Rep       Date:  2017-09-23       Impact factor: 4.810

Review 7.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

Review 8.  Impact of hypoglycemic agents on myocardial ischemic preconditioning.

Authors:  Rosa Maria Rahmi Garcia; Paulo Cury Rezende; Whady Hueb
Journal:  World J Diabetes       Date:  2014-06-15

Review 9.  The genetic and epigenetic basis of type 2 diabetes and obesity.

Authors:  A W Drong; C M Lindgren; M I McCarthy
Journal:  Clin Pharmacol Ther       Date:  2012-10-10       Impact factor: 6.875

10.  The reliability and validity of the Malay version 17-item Diabetes Distress Scale.

Authors:  B H Chew; F Mukhtar; M S Sherina; F Paimin; N H Hassan; N K Jamaludin
Journal:  Malays Fam Physician       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.